Chemo4METPANC Combination Chemotherapy in Patients With Pancreatic Adenocarcinoma

Conditions:   Pancreatic Cancer;   Adenocarcinoma of the Pancreas;   Adenocarcinoma Interventions:   Drug: Motixafortide (BL-8040);   Drug: Cemiplimab;   Drug: Gemcitabine;   Drug: Nab paclitaxel Sponsors:   Gulam Manji;   Regeneron Pharmaceuticals;   BioLine Rx Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials